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Psychometric evaluation of the Persian version of the Doloplus-2 (P-Doloplus-2) scale in
elderly with dementia
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Background/aim: A scale for behavioural pain assessment is useful for the detection and determination of pain in the elderly with
dementia. This study aimed to translate and evaluate the psychometric properties of Doloplus-2 in the elderly with dementia in Iran.
Materials and methods: In this methodological study, after translation and evaluating the face and content validity of Doloplus-2,
100 elderly people were selected by the convenience sampling method in Kashan, 2018–2019. Exploratory factor analysis, convergent
validity, and known-groups comparison were applied to determine construct validity. Reliability was also assessed through internal
consistency, equivalence, and stability methods were used. The ceiling and floor effects were also examined. Data were analyzed using
the SPSS-v16 and via Mann-Whitney U test, Cronbach’s alpha, Spearman-Brown, and intraclass correlation coefficient (ICC).
Results: The scale’s content validity index was 0.95%, and the item impact of each item was above 1.5. Factor analysis identified 2 “socialfunctional” and “conventional subjective-objective” factors in scale that altogether were able to explain 76% of the total variance. The
results revealed that P-Doloplus-2 could discriminate between the 2 groups of elderly with and without known chronic painful diseases
(P < 0.0001). There was a significant positive correlation between P-Doloplus-2 and PACSLAC-II-IR scores (r = 0.878, P < 0.0001).
Cronbach’s alpha, ICC, and standard error of measurement for the scale were 0.950, 0.864, and ± 1.759, respectively. The frequency of
minimum and maximum possible score of scale was less than 15%.
Conclusion: The Persian version of Doloplus-2 can be considered as a valid and reliable scale for pain assessment in the elderly with
dementia.
Key words: Weights and measures, aged, dementia, pain, psychometrics

1. Introduction
Pain is a common problem among elderly people with
dementia [1]. International studies have reported a pain
prevalence of 17% to 79.5% in the elderly with dementia
living in nursing homes [2]. Studies in Iran on communitydwelling elderly people reported a pain prevalence rate
of 79.8%–82.4%, but no separate statistics have been
reported for the elderly with dementia [3,4]. Pain occurs in
the elderly for a variety of reasons, such as musculoskeletal
disorders, ischemia, neuropathy, or malignancies [2];
if it continues, will cause severe consequences such
as depression, anxiety, social isolation, sleep disorder,
sedentary behaviour, reduced quality of life [5].
Despite the prevalence and significant consequences
of pain in the elderly with dementia, pain in this group
is often ignored and underestimated due to a variety
of reasons, including addiction to analgesics, concern
about the side effects of analgesics, and widely held

misconceptions about the inevitability of pain among
elderly people [6,7]. In addition, dementia can cause
memory impairment, aphasia, apraxia, and agnosia and
gradually affect all functional aspects of the individual.
This issue can cause a greater tendency to ignore the pain
in this group [6]. On the other hand, in some patients, pain
appears in the form of some symptoms like aggression,
restlessness, various mood disorders, hallucinations, and
delusions that can sometimes be confused with dementia
symptoms due to their similarities and may lead caregivers
to use antipsychotic medications. This issue is of serious
concern because of the possible side effects of taking such
medicines [8]. Therefore, assessment and proper detection
of pain and its severity are essential in implementing
effective therapy in the elderly with dementia.
Regarding the subjective concept of pain, self-report is
often represented as “the gold standard” in the assessment
of pain [7,8]. Although this method of pain assessment is
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often used at the onset of dementia, its use will be questioned
as the disease progresses and patients lose their ability to
communicate. Therefore, considering the conditions of
patients with dementia, behavioural symptoms of pain
should be taken into account in the evaluation of pain in
this group [8]. The American Geriatrics Society (AGS)
has organized and presented behavioural pain indicators
in 6 different behaviours in the elderly with dementia [9].
Based on which different tools were developed for pain
assessment among these patients over the past few years
[8,10]. In Iran, however, nonspecific pain rating scales
such as a verbal descriptor scale (VDS) and faces pain scale
(FPS) are used to measure pain in this group of patients
[3,4]. Considering the incidence of aphasia, agnosia, and
other sensory-motor disorders in patients with dementia,
and the nature of these scales, their use in such patients
are severely restricted [8]. Haghi et al. translated and
evaluated the psychometric properties of the PACSLACII (the pain assessment checklist for seniors with limited
ability to communicate-II) as a specific tool to measure
pain in patients with dementia [11]; however, this tool has
many items and some relatively specialized concepts, and
this feature limits its use.
According to the findings of several studies conducted
on pain assessment scales in the elderly with dementia, the
Doloplus-2, a pain behavioural assessment scale, seems to
be a useful scale in the diagnosis of pain and determination
of pain severity. This scale can provide a wide range of
behavioural pain indicators in dementia patients [9],
can be easily used by professional caregivers [8], and
its psychometric properties appear to be favourable in
different communities [12–17].
Doloplus-2 was developed by Wary et al. in France
in 2001 [12] to assess pain in nonverbal cognitively
impaired older adults [18]. This scale developed for the
multidimensional assessment of pain. It consists of 3
dimensions and a total of 10 items: somatic reactions (5
items), psychomotor reactions (2 items), and psychosocial
reactions (3 items). Each item is levelled with 4 behavioural
descriptions representing increasing severity of pain rated
from 0 to 3. Individual item scores are summed to arrive at
a total score ranging from 0 to 30 scores. Score 5 indicates
pain [12,18]. Doloplus-2 as one of the most widely used
pain assessment tools in patients with dementia have
been currently translated into English, Dutch [13,19],
Norwegian [14], Italian, Spanish, Portuguese [13],
Japanese [15], and Chinese [16] and its psychoanalysis has
been done. In all different translated versions, the desired
level of psychometric properties has been verified.
By searching the national and international electronic
scientific databases available to the authors of the article,
no study has been conducted on translation, psychometric
validation, or the use of the Doloplus-2 in Iran. Given the
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strengths of the scale, the present study was conducted
to translate the Doloplus-2 into Persian and evaluate its
psychometric properties, as a pain-behavioural assessment
scale, among elderly people with dementia in Iran.
2. Materials and methods
This methodological study focusing on translation and
psychometric evaluation of the Doloplus-2 scale was
conducted in 2 phases in Kashan city, Iran, during 20182019.
2.1. Phase I: translation of the scale
At this phase, the Doloplus-2 scale was translated
according to Wild et al. (2005) guideline [20]. Accordingly,
in the first step (preparation), after gathering the required
information about the intended scale, and getting
permission from its developers by Email, translation and
psychometric evaluation of the scale was performed. In the
second step (forward translation), the English version of
the Doloplus-2 was translated into Persian independently
by 2 translators fluent in both Persian and English and
familiar with health literature in the aging field. At the
reconciliation step, the translated texts were reviewed in
an expert panel consisting of members of the research
team, and they reviewed the translations to achieve the
best possible version. The Persian version of the scale
approved by the expert panel, along with the original
version, was given to a person with expertise in the related
field and Persian literature to evaluate the scale in terms of
appropriate equivalent vocabularies and grammar. Then,
his points of view were reviewed by the research team, and
the necessary corrections were made.
In the next step (back-translation), the primary
form of the translated version was back-translated into
English by a person fluent in English and Persian, familiar
with relevant texts and independent of the individuals
involved in the forward translation process. During the
back-translation review, the Persian version, the original
version, and the English back-translation were reviewed
by the members of the research team, and disagreements
were discussed, agreed upon by both the researchers and
the back-translator and final revisions were made. At
the harmonization step, the revised English translated
version was sent to the designers of the scale to investigate
the conceptual conformity of the revised version with
the original version, and they approved the conformity
of the new version. In the cognitive debriefing step,
10 caregivers (who were diverse regarding age, sex,
education, and work experience) were recruited to assess
whether the vocabularies used in the scale are appropriate
and understandable. By conducting an individual and
face-to-face interview with each of the caregivers, they
were asked about each of the items, words that were
not understandable, and their equivalents, which they
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believed to be more common and comprehensible. In the
review of cognitive debriefing results and finalization, the
research team made the necessary adjustments to the scale
with respect to the questions and ambiguities raised by the
caregivers in the cognitive stage. At the proofreading and
final report step, a Persian version was finally reviewed
by a research team and a Persian language editor in order
to resolve the grammatical and writing problems, and a
primary version of the Doloplus-2 scale was prepared to
investigate its psychometric properties [20].
2.2. Phase II: psychometric evaluation of the scale
This phase was implemented in 4 steps:
2.2.1. The first step: evaluation of face and content
validity
For face and content validity assessments, the Persian
version of the Doloplus-2 scale was provided to 10 experts
in different fields of neurology, geriatrics, psychiatry,
psychology, and psychometrics [21]. Regarding the
qualitative assessment of the scale, they were asked to
comment on the comprehensibility, grammaticality,
literature, scoring, components, and totality of the scale,
and adequacy, clarity, and simplicity of the items [22] and
accordingly, the necessary changes were made.
Content validity was quantitatively assessed by
calculating the content validity ratio (CVR), content validity
index (CVI), and modified kappa statistic [21]. Experts
were asked to rate the essentiality of each item on a 3-point
Likert scale for CVR strict calculation and its relevance on
a 4-point Likert scale for CVI and modified kappa statistic
calculation [22]. The Lawshe table [23], Waltz and Bausell’s
(1981) index [24], and Polit and Beck’s (2012) approach
[25] were used to assessing the results of the CVR, CVI,
and the modified kappa statistic, respectively. The S-CVI/
Average was also used to calculate the total CVI [25].
For quantitative face validity assessment, the same
experts were asked to rate the importance of each item on a
5-point Liker scale and then, their rating scores were used
to calculate item impact score. Item impact score above
1.5 was considered to be optimal [21,26]. Regardless of
the investigations carried out by the experts for qualitative
assessment of face validity, each one of the 10 caregivers
(who were diverse with respect to age, sex, education, and
work experience) were asked to answer each question of
the questionnaire separately and express their perception
about each question. Then the respondents’ perceptions
were compared with the main intention of the question
[26].
2.2.2. The second step: data collection to assess construct
validity (factor analysis, known-groups comparison, and
convergent validity), reliability and the ceiling and floor
effects
Some statisticians believed that in factor analysis, the
number of samples should be 5 to 10 times the number

of tool items [27]; since the Doloplus-2 contains 10 items,
the minimum number of samples needed was estimated
to be 100, 10 samples for each item, in the sample size
calculation formula. The inclusion criteria in this study
were: having Iranian citizenship, age 60 and over, having
dementia based on the neurologist diagnosis by interview
and CT scan, lack of mental retardation based on the
neurologist diagnosis, having hearing ability to cooperate
in implementing a standard mobility protocol, satisfaction
with participation in the study (by obtaining consent from
the patient and his/her legal guardian or caregiver of the
elderly), no use of analgesics 6 h before the assessment,
permanent residency for at least 1 month for elderly people
residing in nursing homes and having qualified caregivers
(taking care of elderly with dementia at home for at least
4 days per week for at least 1 month or at least 4 shifts
per week for at least 1 month in the elderly care centers).
The exclusion criterion was the voluntary withdrawal of
the participant or his/her caregiver/guardian from the
study. Sampling was done by convenience sampling in 2
nursing homes and a private neurology clinic in Kashan
from December 2018 to June 2019.
After obtaining the necessary authorizations from
the relevant authorities, and receiving introduction letter
from the vice chancellor for research and technology of
the Kashan University of Medical Sciences, the researcher
referred to two nursing homes and a private neurology
clinic in Kashan, to extract a list of the elderly with dementia
under the supervision of these centers and contact
their legal guardians. If the elderly and his/her primary
caregiver were eligible and consented to participate in the
study, an appointment for assessment was made with each
participant’s guardian. Then, we attended the appointment
for data collection.
Data were collected by demographic questionnaire,
the Persian-clinical dementia rating (P-CDR) [28],
Doloplus-2 and PACSLAC-II-IR [11] through observation
and interview with the patient and his/her caregiver and
based on the patient’s record.
The demographic questionnaire included 8 questions,
including age, sex, marital status, education, employment
status, place of residence, history of known chronic painful
diseases, and name of the diseases.
The Persian version of the CDR scale includes 75
questions, which should be asked from the participants
and their companion in 6 areas, including memory, spatial
or temporal orientation, judgment and problem solving,
community affairs, home activities and leisure, and personal
affairs. Each area scored on a scale from 0 to 3; the total
score in the scale ranges from zero to 18. Scores of 0, 0.5–2,
2.5–4, 4.5–9, 9.5–15.5, and 16–18 are considered as normal
cognitive status, suspected cognitive impairment, very
mild cognitive impairment, mild cognitive impairment,
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moderate cognitive impairment, and severe cognitive
impairment, respectively. Psychometric validation of  the
Persian version of this scale was carried out by Sadeghi et
al. (1390) in Iran; the experts of the field confirmed its face
and content validity, and its reliability coefficient using
Cronbach’s alpha was estimated 0.73 [28].
The Doloplus-2 consists of a list of 10 items divided
into 3 subgroups: 5 somatic reactions items (somatic
complaints, protective body postures adopted at rest,
protection of sore areas, expression, and sleep pattern), 2
psychomotor reactions items (washing and/or dressing,
and mobility) and 3 psychosocial reactions items
(communication, social life, and problems of behavioural).
Each item is scored from 0 to 3, where 0 is “absent”, and 3
is “the highest score of the behaviour”. It gives a range from
0 to 30, with higher scores indicating more pain severity.
The cut-off score between ‘pain’ and ‘no pain’ was set at
5, as recommended by the scale’s developers [12]. The
concurrent validity of this scale has been verified by the
VDS, pain assessment in advanced dementia (PAINAD),
and the PACSLAC scales [8]. Cronbach’s alpha coefficient
and intraclass correlation coefficient (ICC) in different
studies were reported to be 0.67–0.87 and 0.75–0.97,
respectively [12,13,29].
The original version of the PACSLAC-II scale was
developed by Chan et al. (2014) to assess pain in elderly
people with severe dementia [30] and translated into the
Persian language by Haghi et al. (2019) [11]. The Persian
version of this scale contains 30 items, each item being
rated as 0 (no pain) or 1 (pain). This scale scores the pain
from 0 to 30, with a higher score indicating more severe
pain behaviour. Its validity has been verified by factor
analysis and concurrent validity. Also, the ICC between
the raters was estimated to be 0.76 [11]. In the present
study, the reliability of this scale by computing the KuderRichardson 21 coefficient (KR21) was 0.78.
The P-CDR was used to determine the severity
of dementia in all the samples. The participants were
examined at rest and during the standard mobility protocol
presented by Husebo et al. using the pain assessment scales
(Doloplus-2 and PACSLAC-II-IR) (Table 1) [31]. If the
patient was not cognitively or physically able to perform
the steps of the protocol, a qualified caregiver was recruited
to help him/her. If either of them refused each of the steps,
the participant was excluded from the study.
In order to increase accuracy in completing the pain
assessment scale at rest and during the mobility protocol,
participants were videotaped.
2.2.3. The third step: evaluation of construct validity
(factor analysis, known-groups comparison, and
convergent validity) and the ceiling and floor effects
After data collection, construct validity was evaluated
by exploratory factor analysis, known-groups validity,
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Table 1. Standard mobility protocol of Husebo et al. (2010).
Step Actions
1

To open both hands (one hand at a time)

2

To stretch both arms towards the head (one arm at a time)

3

To stretch and bend both knees and hips (one leg at a time)

4

To turn in bed to both sides

5

To sit at the bedside

and convergent validity. Principal axis factoring (PAF)
method with varimax rotation was used to extract data
in exploratory factor analysis. Eigenvalue above 1 and
the scree plot were used to determine the number of
factors. The minimum load factor was estimated to be 0.52
based on Formula 1 in which “n” is the sample size [22].
Regarding the common factor loadings, the bigger factor
loading was considered.
Critical Value = 5.152 ÷ √(n - 2)
Formula 1
To compare the known-groups, the elderly with
dementia were divided into 2 groups with known chronic
painful diseases and the nondiseased. Then, the scores
obtained for the Doloplus-2 were compared between the
2 groups. The Persian version of the Doloplus-2 and the
PACSLAC-II-IR scale were completed simultaneously for
all participants in the convergent validity assessment.
The ceiling and floor effects of the scale were assessed
[32]; so that the ceiling and floor effects were evaluated
based on the relative frequency of the samples with the
highest and lowest possible attainable scores, respectively.
2.2.4. The fourth step: reliability assessment
The reliability of the Persian MPS was assessed via the
internal consistency, equivalence, and stability.
The internal consistency of the scale was evaluated by
calculating Cronbach’s alpha coefficient.
For equivalence assessment, the scale was completed
for 20 samples selected from the elderly of nursing homes
simultaneously and independently by 2 individuals (first
author of the paper and one trained caregiver), and the
interrater agreement was estimated.
The standard error of measurement (SEM) was also
calculated to evaluate the stability of the scale [33].
2.3. Data analysis
Data were analyzed using the SPSS software version
16. Quantitative variables were described by using
central tendency and dispersion indices and categorical
variables described by absolute and relative frequencies.
Additionally, CVI, CVR, and modified kappa statistic
were used for evaluating quantitative content validity,
and quantitative face validity was analyzed using an
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impact score method. The Kolmogorov-Smirnov test
analyzed the normality of quantitative data. The KaiserMeyer-Olkin (KMO) and Bartlett’s test of sphericity were
used to determine the suitability of the data for factor
analysis. Spearman-Brown test was used to investigate
the correlation between the scores of the Persian version
of Doloplus-2 with the PACSLAC-II-IR scale, MannWhitney U test for comparing known-groups, Cronbach’s
alpha coefficient for assessing internal consistency, and
ICC and the weighted kappa were used to examine the
ICC.
The SEM was calculated based on Formula 2, where
“SD” is the standard deviation of the scores, and “r” is the
Cronbach’s alpha coefficient [33]. In all the analyses, the
significance level was set at P < 0.05.
SEM = SD √1 - r
Formula 2

phrase of “Reduce his/her walking distance” was changed
to the phrase of “Has lower mobility”. In quantitative
content validity assessment, the CVR of all the scale items
ranged from 0.8 to 1, which is higher than the number in
the Lawshe table (0.62 for 10 experts). The CVI calculated
for each item ranged from 0.8 to 1, which is higher than
the minimum acceptable value based on the Waltz and
Basel index (0.79). The modified kappa statistic also
ranged from 0.791 to 1, which was higher than 0.74. The
S-CVI/Average was estimated to be 0.95. In the qualitative
face validity phase, no changes were made on the scale. In
the quantitative face validity assessment, the impact score
of all items was above 1.5 (3.44 to 5).
3.2.2. Evaluation of construct validity (factor analysis,
known-groups comparison, and convergent validity) and
the ceiling and floor effect
A total of 127 older adults were included in the current
study. Of whom, 24 cases declared (by yourself or by their
guardians) that they were not willing to participate in
the study, and 2 persons were not included in the study
because of concomitant mental retardation; 1 person was
excluded from the study due to dissatisfaction of his/her
legal guardian. Finally, data of 100 samples were analyzed.
The age range of the participants was from 65 to 93 years,
with a mean age of 87.310 (± 8.497) years. Fifty-four
percent of the participants were residing in their homes,
and 27% had mild dementia (Table 2).

3. Results
3.1. The translation phase of the scale
The draft of the Persian version of the Doloplus-2 had 10
items with a 4-point Likert scoring style (Appendix 1).
3.2. Psychometric evaluation of the scale
3.2.1. Evaluation of face and content validity
In qualitative content validity assessment, minor
modifications were made to the draft of the Persian version
of the Doloplus-2; for example, in one of the items, the
Table 2. Demographic characteristics of samples (n = 100).
Characteristics
Sex

Marital status

Education

Type of known chronic
painful diseases* (n = 37)

n

%

Characteristics

n

%

Male

29

29

Female

71

71

Place of
residence

Home

54

54

Nursing home

46

46

Single

14

Married

34

14

Employed

0

0

34

Unemployed

3

3

Divorced/separated

12

12

Retired

11

11

Widowed

40

Illiterate

76

40

Disabled

86

86

76

Mild

27

27

Read and write

6

6

Elementary school

8

8

Moderate

53

53

Severe

20

20

High school

5

5

Above diploma

5

5

Yes

37

37

No

63

63

Skin and mucosal ulcers (such as pressure ulcers and skin cuts)

26

70.27

Musculoskeletal disorders (such as arthritis, vertebral disc, spinal stenosis,
fibromyalgia, muscle tension, etc.)

12

32.43

Rheumatic diseases (such as rheumatoid arthritis, osteoarthritis, gout, lupus, etc.)

7

18.92

Employment
Status

Severity of
Dementia
Known chronic
painful diseases

* The relative prevalence of the types of known chronic painful diseases was calculated in 37 samples of these diseases. Since some people
had more than 1 known chronic painful diseases, the sum of the percentages was more than 100.
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Regarding the suitability of the scale for performing
factor analysis, KMO indicated the adequacy of the
number of samples (0.870); the Bartlett test also showed
that the interitem correlation matrix had no problem
for analysis (χ2 = 1125.943, P < 0.0001). Factor analysis
resulted in the extraction of 2 factors. The “functionalsocial” dimension (7 items) with an Eigenvalue of 4.386
and the “conventional subjective-objective” dimension (3
items) with an Eigenvalue of 3.228 were able to explain
43.859% and 32.283% of the total variance, respectively.
These factors altogether could explain 76.142% of the total
variance (Table 3 and Figure).
In the known-groups comparison analysis, the
pain intensity determined by the Persian version of the
Doloplus-2 in the 2 groups with and without known
chronic painful diseases were 18.270 (± 5.738) and 6.920
(± 5.589), respectively, which the results of the MannWhitney U test showed a significant difference (P <
0.0001).
In the convergent validity analysis, the scores
obtained from the Doloplus-2 and PACSLAC-II-IR scales
for the studied items were 11.120 (7.865) and 11.260
(5.425), respectively. There was a significant and positive
correlation between these 2 scores (r = 0.878, P < 0.0001).
Also, there was a significant positive correlation between
the first and second factors of the Persian version of the

Doloplus-2 with the PACSLAC-II-IR scale (r = 0.832 and r
= 0.808, respectively, P < 0.0001).
As with the results of the floor and ceiling effects
analyses, the relative frequencies of the minimum and
maximum possible scores obtained from the Persian
version of the Doloplus-2 were 2% and 0% (less than 15%),
respectively.
3.2.3. Evaluation of reliability
In the internal consistency analysis, the results showed that
a Cronbach’s alpha coefficient for the total scale was 0.950
and for the first and second factors were 0.944 and 0.903,
respectively.
In the equivalence analysis for the total score of scale,
the ICC coefficient between the scores of the raters was
0.864 (CI95%: 0.655–0.946, P < 0.0001). Also, for each item,
the coefficient of agreement between the raters (weighted
kappa) ranged from 0.640 to 0.919 (P < 0.0001) (Table 4).
The SEM of the scale was ± 1.759.
4. Discussion
The present study aimed to translate and assess the
psychometric properties of the Doloplus-2, as a behavioural
pain assessment scale, in the elderly with dementia in Iran.
It was found that the Persian version of the scale could
determine pain severity in a range of 0 to 30 and had a
desirable validity and reliability in the target population.

Table 3. Communalities and factor loadings of items of the extracted factors in the Persian version of the
Doloplus-2.
Extracted factors*

No.

Item theme

1

Somatic complaints

2

Protective body postures adopted at rest

0.733

3

Protection of sore areas

0.611

4

Expression

5

Sleep pattern

0.762

0.655

6

Washing and/or dressing

0.824

0.695

7

Mobility

0.788

0.862

8

Communication

0.728****

9

Social life

0.794

10

Problems of behavioural

First**

Second***
0.908

Communalities
0.912
0.764
0.546

0.909

0.580

0.908

0.867
0.816

0.571

0.592

* The minimum factor loaded for each item was set 0.52. Factor loadings less than 0.52 were not inserted in
the table.
** Considering the content of the items, the first factor (including questions 2, 3, 5, 6, 7, 8, and 9) was named
the “social-functional” dimension.
*** Regarding the content of the items, the second factor (including questions 1, 4, and 10) was named the
“conventional subjective-objective” dimension.
**** In relation to the common loading factor, the item was loaded onto a factor having a larger loading factor.
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4
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Figure. Scree plot of the Persian version of the Doloplus-2 scale.
Table 4. The weighted kappa coefficient of the items in the Persian version of the Doloplus-2 (2 raters and 20 samples).

No.

Item theme

Kappa*

SE

1

Somatic complaints

0.643

2

Protective body postures adopted at rest

3

Protection of sore areas

4
5

Confidence interval 95%

P-value

Lower bound

Upper bound

0.167

0.315

0.971

0.003

0.640

0.164

0.319

0.961

0.003

0.687

0.104

0.482

0.891

0.002

Expression

0.759

0.068

0.626

0.892

0.001

Sleep pattern

0.750

0.080

0.594

0.906

0.001

6

Washing and/or dressing

0.856

0.066

0.727

0.985

< 0.0001

7

Mobility

0.824

0.094

0.639

1.000

< 0.0001

8

Communication

0.919

0.053

0.815

1.000

< 0.0001

9

Social life

0.866

0.082

0.706

1.000

< 0.0001

10

Problems of behavioural

0.848

0.060

0.731

0.966

< 0.0001

* The weighted kappa coefficient calculated for each item is of quadratic type.

In the translation phase of the scale, an attempt was made
to maintain the maximum semantic and technical similarity
of the text using the optimal translation equivalents and
standard translation. If there are semantic equations,
cognitive and perceptual terms in the translation process, it
can be argued that this tool is consistent with the principles
of cultural adaptation and is intended for the target group to
understand the phrases correctly and easily [34].
The results of qualitative content validity showed that
the items were approved by the relevant experts in terms
of intelligibility, grammar, literature, clarity, and simplicity.
Also, considering the desirable values obtained from the
calculation of the CVR (above 0.62), CVI (above 0.79) and
modified kappa statistic (above 0.74), it can be claimed

that the criteria for content validity are met in the Persian
version of the scale [21].
In qualitative face validity analysis, the scale items were
not changed, which confirms the appropriateness of the
items of the Persian version of the scale from the viewpoint
of the experts and caregivers [34]. Unchanged items at this
stage may be due to the use of Wild et al. (2005) guideline
for the translation of the scale since the cognitive debriefing
of the scale is one of the stages of its completion [20].
Also, quantitative face validity assessment indicated that
the item impact scores of all items were more than 1.5,
which confirms the face validity of the scale. Therefore,
the face validity of the Persian version of the Doloplus-2 is
confirmed.
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Construct validity through exploratory factor analysis
identified 2 factors in the Persian version of the Doloplus-2,
namely “social-functional” and “conventional subjectiveobjective”. The social-functional dimension includes
items that examine the individual and social functioning
of older adults with dementia, such as sleep, mobility,
and communication patterns; Whereas the conventional
subjective-objective dimension refers to the most
common symptoms of pain, such as physical complaints
and altered facial expression. The extracted factors were
more than 43% and 32%, respectively, and could explain
over 76% of the total variance. These numbers, according
to Wipulanusat et al. (2017), indicated excellent construct
validity [35]. Therefore, the construct validity of the
Persian version of the Dololplus-2 scale was confirmed.
The results of the study by Neville and Ostini (2014)
showed that Doloplus-2 is a single-factor scale. Also, the
percentage of variance explained in their study was lower
than in the present study [29]; however, unlike the present
study, the data were collected by multiple raters. In a
study aimed to assess the psychometric properties of the
Chinese version of Doloplus-2, 3 factors were identified in
the scale that was able to explain 65% of the variance of the
score [16]. Regardless of the differences in the severity of
dementia in the studied samples, the use of multiple raters
for pain assessment in the studies can be the cause of this
difference.
The results of the construct validity assessment using
known-groups comparison showed that the Persian
version of Doloplus-2 could discriminate between the 2
groups, with and without known chronic painful diseases.
Therefore, it can be noted that the scale is able to detect the
pain and its severity.
Convergent validity showed a strong, positive, and
significant correlation between total score and the score of
each subscale of the Persian version of the Doloplus-2 with
the PACSLAC-II-IR scale. Many researchers believe that a
correlation of 0.5 indicates strong convergent validity [22].
Some experts, however, do not consider those too high
coefficients to be desirable and accordingly emphasize that
both scales (the existing and new scales) are the same, and
there is no need to introduce new ones. However, they
acknowledge that the new scale due to its nature can be a
good alternative scale [36]. Although the Persian version
of the Doloplus-2 (with 10 items) has fewer items than
the PACSLAC-II-IR scale (with 30 items), it covers a wide
range of behavioural pain indicators; therefore, its use for
accurate assessment of pain by caregivers and researchers
seems to be preferable. The results of Pautex et al. (2007)
study confirmed the convergent validity of the Doloplus-2
and visual analogue scale (VAS), which are in line with the
results of the present study [17].
The relative frequency of the minimum and maximum
scores obtained from the Persian version of the Doloplus-2
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were less than 15%, meaning that the scale had no ceiling
and floor effects [32]. The lack of ceiling and floor effects
refer to including items on the scale that represent the
maximum and minimum intensity of the pain, respectively.
The existence of appropriate items can confirm the content
validity and stability of the scale [22,32].
Cronbach’s alpha coefficient was 0.95 for the total
scale and above 0.9 for each of its subscales. Given that
the coefficient is higher than 0.7 [37], it can be stated
that the scale has good internal consistency. Internal
consistency of the Doloplus-2 has been reported in studies
ranging from 0.58 to 0.87 [8,12,16,19,29]. The reason for
the difference between the results of these studies and the
present study may be because of differences in the number
and characteristics of the studied samples, including
age, severity of dementia, residence of place, and other
demographic information.
The ICC of the Persian version of the Doloplus-2
was 0.864. Also, the calculated kappa coefficient for each
item was between 0.640 and 0.919. Koo and Li (2016)
consider the ICC of 0.6 or more as acceptable reliability
[38]. Therefore, the results show that the coefficient of
agreement between the raters is desirable. The coefficient
of agreement between the raters was reported between 0.47
and 0.96 in similar studies [8,13,15,16,29]. The difference
between the results of these 2 studies may be due to the
quality of the training provided to the raters (on how to
complete the scale). Because of the nature of the concepts
and terms in the Doloplus-2 scale, in order to achieve the
desired results, it is necessary to educate caregivers on how
to complete the scale which is focused on in this study.
With respect to each item, the kappa coefficients of the
items were reported from 0.19 to 1.00 in similar studies
[13,29]. Regardless of the number of raters and the quality
of training provided to raters on how to complete the scale,
the method of calculating the reported kappa coefficient
should also be taken into account when comparing the
findings of different studies.
The assessment of the absolute reliability of the Persian
MPS revealed a standard error of measurement of ± 1.795,
which indicates that if the scale is completed again for
an individual, its score may be changed by ± 1.795. The
scoring range of the Persian version of the Doloplus-2 was
from 0 to 30, which is low, and thus supports the stability
of the scale [22].
Variation in the characteristics of the units under
the study is one of the strengths of the current study.
Regardless of the relatively small sample size, considering
the known cases of the chronic painful disease can be
considered as a limitation of this study. In future studies,
it is recommended that confirmatory factor analysis be
performed on the Persian version of the Doloplus-2. Also,
it is recommended that a study be repeated with larger
sample size and with respect to the severity of dementia.
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The P-Doloplus-2 scale has 10 items and can be used as
a valid and reliable scale for assessment of pain in patients
with dementia by caregivers and researchers; it can be used
after receiving adequate training on how to complete the
scale.
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